Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can new scanners spot fatty liver without an MRI?

NCT ID NCT07495332

First seen Apr 03, 2026 · Last updated Jun 22, 2026 · Updated 9 times

Summary

This study compares two newer imaging methods—photon-counting CT and ultrasound—against the standard MRI to see how well they detect fat and scarring in the liver. About 45 adults with liver disease will receive all three scans. The goal is to find a faster, cheaper, and equally accurate way to diagnose fatty liver disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FATTY LIVER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke University Medical Center

    RECRUITING

    Durham, North Carolina, 27710, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Photon-counting CT, ultrasound, and MRI imaging tests

What this could lead to

If successful, this could lead to quicker and more accessible ways to diagnose fatty liver disease without needing an MRI.

What could go wrong

This is a small, early-stage study (45 people) comparing imaging methods, not testing a treatment. The new techniques may not match MRI's accuracy in real-world use.

Conditions

The condition(s) this trial relates to.

cirrhosis of liver fatty liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.